WKN: | A2PWSL |
ISIN: | US74365A3095 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
EQS-News: Protalix BioTherapeautics Inc. Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment 30.11.2022 / 21:00 CET/CEST The issuer is solely responsible for ...weiterlesen